Plain english summary
Background
Methods
Eligibility criteria of studies
Type of studies
Type of participants
Type of intervention
Type of outcomes
Search strategy for identification of studies
Process of study identification, selection and data extraction
Risk of bias assessment
Analysis and reporting
Findings
Results of the search
Characteristic |
N (%) |
---|---|
Type of manuscript | |
Articles in peer-reviewed journals | 18 (90.0) |
Congress Abstracts | 2 (10.0) |
Method | |
Quantitative only | 19 (95.0) |
Both qualitative and quantitative | 1 (5.0) |
Study design | |
Randomized controlled trial | 1 (5.0) |
Experimental non-randomized | 1 (5.0) |
Cross-sectional | 12 (60.0) |
Case Control | 1 (5.0) |
Before-and-after intervention | 5 (25.0) |
Region | |
Asia | 9 (45.0) |
Africa | 8 (40.0) |
Europe | 1 (5.0) |
Oceania | 2 (10.0) |
Place of Delivery | |
Health facility based | 3 (15.0) |
Home childbirth | 7 (35.0) |
Both (Home and Health facility) | 10 (50.0) |
Participants | |
Study subjects who received the intervention
| |
Pregnant women | 9 (45.0) |
Birth attendants, health workers, TBAs | 8(40.0) |
Women during childbirth | 5 (25.0) |
Newborns | 1 (5.0) |
Study subjects in which outcomes were assessed
| |
Pregnant women | 5 (25.0) |
Women during delivery | 17 (85.0) |
Neonates | 8 (40.0) |
Women during postpartum | 5 (25.0) |
Infants | 1(5.0) |
Sample size | |
> 10,000 | 5 (25.0) |
10,000–1000 | 6 (30.0) |
< 1000 | 9 (45.0) |
Type of components | |
Only the kits | 5 (25.0) |
Kits + behavioral intervention | 4 (20.0) |
Kits + behavioral + other components | 1(5.0) |
Kits + training | 6 (25.9) |
Kits + training + other components | 4(20.0) |
Author | Year | Number of participants | Country | Home or facility based | Type of study/design | Participants | Components of the Intervention (by study subjects) | Outcomes | |
---|---|---|---|---|---|---|---|---|---|
Study subjects who received the intervention
|
Study subjects in whom the outcomes were measured
| ||||||||
Balsara et al | 2009 | 349 women | Egypt | Home 284 Health facility 65 | Cross-sectional analytical | Health providers TBAs (Dayas) Pregnant women | Pregnant women Women during delivery | CDK (Health providers) CDK + training(TBAs) CDK+ use instructions (Pregnant women) | Number of ANC visits Use of CDK Clean delivery practices CDK acceptability |
Calvert et al | 2007 | 19 women | United Kingdom | Health facility | Cross-sectional study no analytic | Women in labor and delivery | Women in labor, delivery and postpartum | Homeopathic remedies kit (Women in labor and delivery) | Use of kit Benefit during birth |
Darmstadt et al | 2009 | 334 women 6 lost | Egypt | Home 276 Health facility 54 | Cross-sectional study no analytic | TBAs (raedat, dayas, nurses) Community health workers Skilled birth attendants Pregnant women | Women during delivery Newborns | CDK (Health providers) CDK + training(TBAs) CDK+ instructions (Pregnant women) | Cord infection Puerperal infection |
Dickerson et al | 2010 | 980 women 378 outreach providers | Tibet | Home 452 Health facility 495 | Cross-sectional study no analytic | Pregnant women Outreach Health workers Laypersons | Women during delivery | CDK + training (to all) + antenatal and postnatal micronutrient supplementation(women) | Use of CDK Use of beneficial practices Breast-feeding |
Garner et al | 1994 | 126 women 131 neonates | Papua New Guinea | Home | Before and after study | Pregnant women | Neonates | CDK+ use instructions (women) | Neonatal sepsis Use of the kits Fever |
Greenwood | 1990 | 15 villages with PHC and non-PHC; 673 women before the introduction of the Program and 1913 after | Gambia | Home | Before and after study | TBAs | Pregnant women Women during delivery Newborns Women during postpartum period | Training + obstetric packagea(TBA) | Number of ANC visits Maternal mortality Maternal morbidity Perinatal mortality Stillbirth Neonatal death Tetanus immunization Pre-eclampsia |
Hassan et al | 2012 | 225 women 82 health workers | Pakistan | Home 100 Health facility 125 | Cross-sectional, questionnaire study, no analyticc
| TBA, women. | Women during delivery Health workers | CDK | Use of CDK Use of clean delivery practices |
Jokhio et al | 2005 | 19,557 women TBAs | Pakistan | Home | Experimental randomized cluster trial | TBAs in seven talukas (rural Larkana) | Pregnant women Women during delivery | CDK + training (TBAs) VS NO training/NO CDK | Perinatal mortality Maternal mortality hemorrhage obstructed labor puerperal sepsis eclampsia, abortion Referral |
Kapoor et al | 1991 | 7687 deliveries | India | Home 6652 Health facility 1035 | Cross-sectional study no analytic | TBAs Pregnant women | Pregnant women Women during delivery Neonates | Training to conduct deliveries(TBAs) CDK + tetanus toxoid immunization + Training in Clean delivery practices (women) | Tetanus toxoid coverage Neonatal mortality Tetanus neonatal mortality |
McDougal et al | 2012 | 1545 women | Lesotho | Health facility | Before and after study | Pregnant women | Pregnant women Women during delivery Women during postpatum Infants | MPPb: pregnancy, Intrapartum and 7 day post-partum ARVs (women) + neonatal ARVs for 7 or 28 days(infants) | Number of ANC visits HIV Positive women with 4 antenatal visits HIV negative women with 4 ANC visits Children with DNA PCR test at 53 months |
Meegan et al | 2001 | 118,160 births | Kenya Tanzania | Home Health facility | Experimental non-randomized clinical trial | TBAs | Neonates | CDK + training (TBAs) | Neonatal tetanus Mortality under 6 weeks |
Mukasa et al | 2012 | 3116 women | Uganda Tanzania | Home Health facility | Cross-sectional study no analytic | Pregnant women | Women during delivery | CDK + misoprostol + information(women) | Use of CDK Acceptability |
Ouma et al | 2012 | 7080 deliveries before 8269 deliveries after | Kenya | Health facility | Before and after study | Birth attendants (BA) | Women with an obstetric emergency | Obstetric emergency kit (BA) | Maternal mortality due to hemorrhage, pre eclampsia/eclampsia, cardio pulmonary arrest |
Quaiyum et al | 2012 | 118,594 women | Bangladesh | Home | Before and after study | TBAs Pregnant women from selected upazilas
| Women at delivery | CDK + misoprostol + blood collection mat + training (TBAs and women) | Maternal mortality |
Raza et al | 2013 | 420 neonates | Pakistan | Home 311 Health facility 109 | Matched Case-control study | Cases: Newborns with tetanus Controls: Newborns without tetanus | No applicable | CDK | Use of CDK Use of hygienic practices |
Seward et al | 2015 | 40,602 deliveries | Nepal India Bangladesh | Home | Cross-sectional analytical | Women during delivery | Women during delivery | CDK training on clean delivery practices (hand washing) | Use of CDK Maternal mortality |
Seward et al | 2012 | 19,754 deliveries | Nepal India Bangladesh | Home | Cross-sectional analytical | Women during delivery | Neonates | CDK training on clean delivery practices | Neonatal mortality |
Tsu | 2000 | 1600 women | Nepal | Home | Cross-sectional analytical | Women who delivered a live newborn | Newborn | CDK | Cord infection Newborn infection Maternal infection |
Vallely et al | 2016 | 200 women | Papua New Guinea | Home 108 Health facility 92 | Cross-sectional analytical | Pregnant women | Women during delivery Women during postpartum | CDK + training + misoprostol (women) | Use of CDK CDK acceptability |
Winani et al | 2007 | 3262 women | Tanzania | Home 1792 Health facility 1186 | Cross-sectional analytical | Pregnant women | Women during delivery Women during postpartum Newborns | CDK + (women’s education) | Use of CDK Cord Infection Puerperal sepsis |
Kits’ effectiveness and safety during pregnancy
Kits’ effectiveness and safety during childbirth and the immediate postpartum period
Soap | Gloves | Clean plastic drape | Sterile razor | Cord tie/clamp | Gauze/cotton | Antiseptic | Newborn cap | Other | Cost of the kit | |
---|---|---|---|---|---|---|---|---|---|---|
Pregnancy | ||||||||||
Mc Dougal 2012 | HIV treatment | unknown | ||||||||
Childbirth | ||||||||||
Clean Delivery Kits
| ||||||||||
Balsara 2009 | x | x | x | x | free | |||||
Calvert 2007 | homeopathic remedies | unclear | ||||||||
Dickerson 2010 | x | x | x | x | x | x | x | vitamins-micronutrients | probably | |
Darmstadt 2009 | x | x | x | x | x | x | free | |||
Garner 1994 | x | x | x | free | ||||||
Hassan 2012 | x | x | x | x | x | x | x | x | unclear | |
Meegan 2001 | x | x | x | free | ||||||
Jokhio 2005 | x | x | x | x | x | x | free | |||
Kapoor 1991 | x | x | x | unclear | ||||||
Mukasa 2012 | x | x | x | x | x | x | misoprostol-blood collection mat | unclear | ||
Quaiyum 2012a
| misoprostol | unclear | ||||||||
Raza 2013 | x | x | x | x | x | unclear | ||||
Seward 2012 | x | x | x | x | x | free/very low cost | ||||
Seward 2015 | x | x | x | x | x | free/low cost | ||||
Tsu 2000 | x | x | x | x | free or cost depending on region | |||||
Vallely 2016 | x | x | x | x | x | misoprostol | free | |||
Winani 2007 | x | x | x | x | free | |||||
Emergency kits
| ||||||||||
Ouma 2012 | not applicable | |||||||||
Obstetric care kit
| ||||||||||
Greenwood 1990 | Scissors, string, dresses, oral ergometrine, balance | unclear |
Global n/N (%) | Home n/N (%) | Health facility n/N (%) | |
---|---|---|---|
Balsara 2009 | 248/349 (71.0) | 214/284 (75.4) | 44/65(67.7) |
Calvert 2007 | |||
Before labour | 12/19 (63.1) | ||
During labour | 15/19 (78.9) | ||
Pospartum | 19/19 (100.0) | ||
Dickerson 2010 | 932/962 (96.9) | ||
Garner 1994 | |||
Razor pack | 22/33 (66.7) | ||
Clamp pack | 17/34 (50.0) | ||
Hassan 2012 | 72/225 (32.0)a
| ||
Jokhio 2005 | 8172/10114 (80.0) | ||
Raza 2013 | |||
Cases | 24/123 (17.1) | ||
Controls | 99/280 (35.4) | ||
Seward 2015 | 5210/34660 (15.05) | ||
Vallely 2016 | 115/200 (57.5) | 99/106 (93.4) | 16/94 (17.0) |
Winani 2007 | 1820/3058 (59.5) |
Intervention group | Control group | OR adjusted IC 95% | |
---|---|---|---|
Cord infection | |||
Darmstadt 2009 | 14/235 | 13/93 | 0.42 (0.18–0.97) |
Tsu 2000 | – | – | 0.45 (0.25–0.81) |
Winani 2007a
| 3/1820 | 48/1238 | 0.04 (0.01–0.12) |
Sepsis | |||
Garner 1994a
| 1/67 | 8/64 | 0.11 (0.01–0.87) |
Seward 2012 | – | – | 0.28 (0.12–0.65) |
Tetanus-specific mortalityb
| |||
Kapoor 1991 | 0 | 14.6 | – |
Meegan 2001c
| 0.75 | 82 | – |
All-cause neonatal mortality | |||
Kapoor 1991b
| 19.9 | 39.2 | – |
Seward 2012 | – | – | 0.51(0.35–0.76) |
Jokhio 2005 | 37 | 53 | 0.71 (0.62–0.83) |
Greenwood 1990a
| 54/1159 | 47/675 | 0.65 (0.44–0.98) |
Stillbirth | |||
Greenwooda
| 61/1220 | 37/712 | 0.96 (0.63–1.46) |
Perinatal mortality | |||
Jokhio 2005b
| 85 | 120 | 0.70 (0.59–0.82) |
Greenwood 1990a
| 99/1220 | 63/712 | 0.91(0.65–1.27) |
Kits group | Control group | OR adjusted IC 95% | |
---|---|---|---|
Puerperal infection | |||
Jokhio 2005 | 78/10093 | 400/9432 | 0.18 (0.14–0.22) |
Darmstadt 2009 | 1/235 | 4/93 | 0.11 (0.01–1.06) |
Winani 2007 | 19/1798 | 50/1380 | 0.28 (0.17–0.48) |
Post partum hemorrhage | |||
Vallely 2016 | 15/112 | 33/88 | 0.25 (0.13–0.52)a
|
Jokhio 2005+ | 174/10093 | 259/9432 | 0.62(0.51–0.75)a
|
Ouma 2012b
| 6/19 (31.6%) | 14/27 (51.9%) | |
Eclampsia | |||
Jokhio 2005d
| 23/10093 | 29/9432 | 0.74 (0.42–1.28)a
|
Maternal mortality | |||
Seward 2015 | – | – | 1.26 (0.62–2.56) / 0.51 (0.28–0.93)e
|
Ouma 2012 | 19/8120 | 27/6935 | 0.60 (0.33–1.08) |
Quaiyum 2012c
| 137 | 338 | – |
Jokhio 2005 | – | – | 0.74 (0.45–1.23) |
Greenwood 1990 | 13/1236 | 7/727 | 1.09(0.94–2.93)a
|